化合物(E)-AG 556 T21853
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 133550-41-1 | ¥6,880.00 | 询底价 |
1 mg | 133550-41-1 | ¥397.00 | 询底价 |
50 mg | 133550-41-1 | ¥4,880.00 | 询底价 |
25 mg | 133550-41-1 | ¥3,320.00 | 询底价 |
10 mg | 133550-41-1 | ¥1,660.00 | 询底价 |
1 mL | 133550-41-1 | ¥997.00 | 询底价 |
500 mg | 133550-41-1 | ¥13,800.00 | 询底价 |
200 mg | 133550-41-1 | ¥9,290.00 | 询底价 |
5 mg | 133550-41-1 | ¥965.00 | 询底价 |
Product Introduction
Bioactivity
英文名: (E)-AG 556
描述: (E)-AG 556 是有效的、选择性 EGFR 抑制剂。(E)-AG 556阻断 LPS 诱导的促炎因子 TNF-α 的产生。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (148.64 mM)
关键字: (E)-Tyrphostin AG 556 | ErbB-1 | AG-556 | EGFR | (E)-AG 556 | (E)AG 556 | Epidermal growth factor receptor | inhibit | AG556 | Inhibitor | HER1 | (E) AG 556 | AG 556
相关产品: PD168393 | A-935142 | ZM323881 hydrochloride | Cetuximab | WZ8040 | Ligustroside | EAI045 | Dacomitinib hydrate | Rilematovir | Pertuzumab
相关库: Anti-Prostate Cancer Compound Library | Anti-Breast Cancer Compound Library | ReFRAME Related Library | Angiogenesis related Compound Library | Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library
化合物(E)-AG 556 T21853信息由TargetMol中国为您提供,如您想了解更多关于化合物(E)-AG 556 T21853报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途